Cargando…
The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021
PURPOSE: To analyze the differences in clinical distribution and antimicrobial resistance of pathogens among northern Anhui, central Anhui, and southern Anhui in 2021, and to provide a basis for the rational use of drugs for clinicians in different regions. METHODS: Nonrepetitive pathogens isolated...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790164/ https://www.ncbi.nlm.nih.gov/pubmed/36575674 http://dx.doi.org/10.2147/IDR.S393760 |
_version_ | 1784859113758392320 |
---|---|
author | Liu, Yanyan Wang, Wei Guo, Mingjuan Xu, Zhicheng Yang, Yi Yu, Liang Li, Yasheng Hu, Lifen Ye, Ying Li, Jiabin |
author_facet | Liu, Yanyan Wang, Wei Guo, Mingjuan Xu, Zhicheng Yang, Yi Yu, Liang Li, Yasheng Hu, Lifen Ye, Ying Li, Jiabin |
author_sort | Liu, Yanyan |
collection | PubMed |
description | PURPOSE: To analyze the differences in clinical distribution and antimicrobial resistance of pathogens among northern Anhui, central Anhui, and southern Anhui in 2021, and to provide a basis for the rational use of drugs for clinicians in different regions. METHODS: Nonrepetitive pathogens isolated from clinical samples of inpatients and outpatients from 59 member units with qualified data in 2021 were obtained from the Anhui Province Antimicrobial Resistance Surveillance System, which was divided into northern Anhui, central Anhui, and southern Anhui by region. Identification and antimicrobial susceptibility analyses were carried out using the Vitek 2 Compact and standard disc diffusion method. The results were determined according to the American Clinical Laboratory Standards Institute in 2021 with data analyzed using WHONET 5.6 and SPSS 17.0. RESULTS: A total of 133,268 pathogenic bacteria were isolated from clinical samples. Staphylococcus aureus (S. aureus) was the most common gram-positive bacterium and Escherichia coli (E. coli) was the most common gram-negative bacterium. Sputum was the main source of clinical specimens. The detection rates of methicillin-resistant S.aureus, methicillin-resistant coagulase-negative Staphylococcus, carbapenem-resistant E. coli, carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae), carbapenem-resistant Acinetobacter baumannii, third-generation cephalosporin-resistant E. coli, and third-generation cephalosporin-resistant K. pneumoniae were higher in northern Anhui than in southern Anhui (P<0.0001). E. coli, K. pneumoniae, and Pseudomonas aeruginosa were sensitive to amikacin. Strains resistant to vancomycin, linezolid, and teicoplanin were not isolated until 2021. CONCLUSION: There were significant differences in bacterial resistance in different regions of Anhui Province. Antibiotic resistance in northern Anhui was the most serious in 2021. Antimicrobial agents must be used according to the resistance of the bacteria in the local region. |
format | Online Article Text |
id | pubmed-9790164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-97901642022-12-26 The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021 Liu, Yanyan Wang, Wei Guo, Mingjuan Xu, Zhicheng Yang, Yi Yu, Liang Li, Yasheng Hu, Lifen Ye, Ying Li, Jiabin Infect Drug Resist Original Research PURPOSE: To analyze the differences in clinical distribution and antimicrobial resistance of pathogens among northern Anhui, central Anhui, and southern Anhui in 2021, and to provide a basis for the rational use of drugs for clinicians in different regions. METHODS: Nonrepetitive pathogens isolated from clinical samples of inpatients and outpatients from 59 member units with qualified data in 2021 were obtained from the Anhui Province Antimicrobial Resistance Surveillance System, which was divided into northern Anhui, central Anhui, and southern Anhui by region. Identification and antimicrobial susceptibility analyses were carried out using the Vitek 2 Compact and standard disc diffusion method. The results were determined according to the American Clinical Laboratory Standards Institute in 2021 with data analyzed using WHONET 5.6 and SPSS 17.0. RESULTS: A total of 133,268 pathogenic bacteria were isolated from clinical samples. Staphylococcus aureus (S. aureus) was the most common gram-positive bacterium and Escherichia coli (E. coli) was the most common gram-negative bacterium. Sputum was the main source of clinical specimens. The detection rates of methicillin-resistant S.aureus, methicillin-resistant coagulase-negative Staphylococcus, carbapenem-resistant E. coli, carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae), carbapenem-resistant Acinetobacter baumannii, third-generation cephalosporin-resistant E. coli, and third-generation cephalosporin-resistant K. pneumoniae were higher in northern Anhui than in southern Anhui (P<0.0001). E. coli, K. pneumoniae, and Pseudomonas aeruginosa were sensitive to amikacin. Strains resistant to vancomycin, linezolid, and teicoplanin were not isolated until 2021. CONCLUSION: There were significant differences in bacterial resistance in different regions of Anhui Province. Antibiotic resistance in northern Anhui was the most serious in 2021. Antimicrobial agents must be used according to the resistance of the bacteria in the local region. Dove 2022-12-21 /pmc/articles/PMC9790164/ /pubmed/36575674 http://dx.doi.org/10.2147/IDR.S393760 Text en © 2022 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Liu, Yanyan Wang, Wei Guo, Mingjuan Xu, Zhicheng Yang, Yi Yu, Liang Li, Yasheng Hu, Lifen Ye, Ying Li, Jiabin The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021 |
title | The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021 |
title_full | The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021 |
title_fullStr | The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021 |
title_full_unstemmed | The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021 |
title_short | The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021 |
title_sort | analysis of drug-resistant bacteria from different regions of anhui in 2021 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790164/ https://www.ncbi.nlm.nih.gov/pubmed/36575674 http://dx.doi.org/10.2147/IDR.S393760 |
work_keys_str_mv | AT liuyanyan theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT wangwei theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT guomingjuan theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT xuzhicheng theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT yangyi theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT yuliang theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT liyasheng theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT hulifen theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT yeying theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT lijiabin theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT liuyanyan analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT wangwei analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT guomingjuan analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT xuzhicheng analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT yangyi analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT yuliang analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT liyasheng analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT hulifen analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT yeying analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 AT lijiabin analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021 |